1. Home
  2. AISP vs KZIA Comparison

AISP vs KZIA Comparison

Compare AISP & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$3.05

Market Cap

85.8M

Sector

Finance

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$12.92

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
KZIA
Founded
2006
1994
Country
United States
Australia
Employees
65
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.8M
100.8M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
AISP
KZIA
Price
$3.05
$12.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.50
AVG Volume (30 Days)
524.9K
187.8K
Earning Date
05-15-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$3.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$3.54
52 Week High
$7.20
$17.40

Technical Indicators

Market Signals
Indicator
AISP
KZIA
Relative Strength Index (RSI) 69.48 52.47
Support Level $2.81 $5.71
Resistance Level $3.92 $14.82
Average True Range (ATR) 0.22 0.99
MACD 0.06 -0.27
Stochastic Oscillator 90.61 30.77

Price Performance

Historical Comparison
AISP
KZIA

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: